Transcatheter Aortic Valve Replacement
"Transcatheter Aortic Valve Replacement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical treatment for severe AORTIC VALVE STENOSIS. Transcatheter aortic valve replacement (TAVR) is used as an alternative option in patients who are deemed at high risk or inoperable for traditional open-heart surgery.
Descriptor ID |
D065467
|
MeSH Number(s) |
E04.100.376.485.500 E04.650.410.500 E04.928.220.410.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Transcatheter Aortic Valve Replacement".
Below are MeSH descriptors whose meaning is more specific than "Transcatheter Aortic Valve Replacement".
This graph shows the total number of publications written about "Transcatheter Aortic Valve Replacement" by people in this website by year, and whether "Transcatheter Aortic Valve Replacement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 2 | 0 | 2 |
2015 | 5 | 1 | 6 |
2016 | 8 | 0 | 8 |
2017 | 6 | 2 | 8 |
2018 | 9 | 0 | 9 |
2019 | 15 | 1 | 16 |
2020 | 23 | 1 | 24 |
2021 | 20 | 2 | 22 |
2022 | 24 | 0 | 24 |
2023 | 15 | 0 | 15 |
2024 | 12 | 1 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcatheter Aortic Valve Replacement" by people in Profiles.
-
Contemporary Outcomes of TAVR Using a Balloon-Expandable Valve in Patients With Severe Mitral Stenosis: Insights From the Transcatheter Valve Therapies Registry. Circ Cardiovasc Interv. 2024 Dec; 17(12):e014216.
-
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials. J Am Heart Assoc. 2024 Nov 05; 13(21):e036179.
-
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients. Circ Cardiovasc Interv. 2024 Nov; 17(11):e014018.
-
Association of Baseline Tricuspid Regurgitation With Health Status and?Clinical Outcomes After TAVR?and?Mitral TEER. JACC Cardiovasc Interv. 2024 Aug 26; 17(16):1905-1915.
-
Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement. Expert Rev Cardiovasc Ther. 2024 Aug; 22(8):409-420.
-
Sutureless Valves, a "Wireless" Option for Patients With Aortic Valve Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 23; 84(4):382-407.
-
3-Year Outcomes From the Evolut?Low Risk TAVR Bicuspid Study. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1667-1675.
-
A Guide to Transcatheter Aortic Valve Design and Systematic Planning for a Redo-TAV (TAV-in-TAV) Procedure. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1631-1651.
-
Assuring Success?: Selecting Patients With Bicuspid Aortic Valves for TAVR. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1664-1666.
-
Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry. Eur Heart J. 2024 Jul 21; 45(28):2519-2532.